Document Detail

Cost-identification analysis in oral cavity cancer management.
MedLine Citation:
PMID:  9482555     Owner:  NLM     Status:  MEDLINE    
The objectives of this study were to investigate potential relationships between pretreatment patient-mix characteristics, treatment modalities, and costs generated during the pretreatment work-up, treatment, and 1-year follow-up periods for patients with oral cavity cancer (OCC). Another objective was to identify potential areas for cost reduction and improved resource allocation in the management of OCC patients. Using a retrospective cohort of 73 patients with OCC, pretreatment patient-mix characteristics and treatment modalities were evaluated in relation to university-based charges incurred during the pretreatment evaluation, treatment, and 1-year follow-up periods. Simple regression and stepwise multiple regression analyses were used to develop predictive models for cost based on independent variables, including age, AJCC TNM clinical stage, smoking history, American Society of Anesthesiologists (ASA) class, comorbidity as defined by the Kaplan-Feinstein grade and treatment modality. The dependent measurements included all physician, office, and hospital charges incurred at the University of Iowa Hospitals and Clinics during the pretreatment evaluation, treatment, and follow-up periods, as well as the total pretreatment through 1-year follow-up management costs. Independent variables that were identified as being significantly associated with treatment costs included T classification, N classification, TNM stage, unimodality versus multimodality treatment, and the Kaplan-Feinstein comorbidity grade. Age, smoking status, and ASA class were not significantly associated with costs. The majority of the OCC management costs were incurred during the treatment period. The most substantial decreases in management costs for OCC will be realized through measures that allow identification and treatment of disease at an early stage, in which single-modality treatment may effectively be used. Resource allocation for OCC should support the investigation of measures through which the diagnosis and treatment of OCC at the earliest possible stage is facilitated. The presence of comorbid illness is a significant component in the determination of management costs for OCC and should be included in analyses of resource allocation for OCC. The singular diagnosis of OCC encompasses a wide range of patient illness severity, and diagnosis-related reimbursement schemes for OCC treatment should optimally differentiate between early and advanced stage disease.
G F Funk; H T Hoffman; L H Karnell; J M Ricks; M B Zimmerman; D P Corbae; D H Hussey; T M McCulloch; S M Graham; C J Dawson; M E Means; M L Colwill; M G Titler; E M Smith
Related Documents :
7663025 - Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intr...
10730835 - A continuous quality improvement approach to il-372 documentation compliance in an acad...
19802545 - Clinical observation on treatment of 32 patients with measles by qingzhen decoction.
18703585 - Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-savi...
21519075 - Popliteal angle as an indicator for successful closed reduction of developmental dyspla...
24068695 - Autologous tenocyte injection for the treatment of severe, chronic resistant lateral ep...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery     Volume:  118     ISSN:  0194-5998     ISO Abbreviation:  Otolaryngol Head Neck Surg     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-03-19     Completed Date:  1998-03-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8508176     Medline TA:  Otolaryngol Head Neck Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  211-20     Citation Subset:  IM    
Department of Otolaryngology-Head and Neck Surgery, University of Iowa College of Medicine, Iowa City, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma, Squamous Cell / complications,  economics*,  mortality,  therapy*
Combined Modality Therapy / economics
Costs and Cost Analysis
Follow-Up Studies
Health Care Costs*
Middle Aged
Neoplasm Staging
Oropharyngeal Neoplasms / complications,  economics*,  mortality,  therapy*
Retrospective Studies
Survival Rate
Tobacco Use Disorder / complications

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Lateral thigh flap reconstruction in the head and neck.
Next Document:  Gender-specific effects of medicinal drugs on hearing levels of older persons.